本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aptevo Therapeutics Inc.

1.82
-0.0100-0.55%
盤前1.81-0.0121-0.66%06:26 EDT
成交量:4.51萬
成交額:8.39萬
市值:327.96萬
市盈率:-0.03
高:1.92
開:1.83
低:1.80
收:1.83
52周最高:48.78
52周最低:1.37
股本:180.20萬
流通股本:165.17萬
量比:0.10
換手率:2.73%
股息:- -
股息率:- -
每股收益(TTM):-58.0829
每股收益(LYR):-82.2951
淨資產收益率:-420.34%
總資產收益率:-111.49%
市淨率:0.54
市盈率(LYR):-0.02

資料載入中...

2021/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/11

重要事件披露

8-K - Current report
2021/05/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/28

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/31

重要事件披露

8-K - Current report
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/17

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/14

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/12/02

重要事件披露

8-K - Current report
2020/11/30

重要事件披露

8-K - Current report
2020/11/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals